Emre Vural
Concepts (292)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mandibular Fractures | 5 | 2013 | 11 | 1.800 |
Why?
| Surgical Flaps | 8 | 2023 | 135 | 1.740 |
Why?
| Skin Transplantation | 7 | 2010 | 50 | 1.460 |
Why?
| Head and Neck Neoplasms | 13 | 2023 | 335 | 1.370 |
Why?
| Graft Survival | 6 | 2019 | 165 | 1.190 |
Why?
| Fracture Fixation, Internal | 4 | 2013 | 46 | 1.190 |
Why?
| Rhinoplasty | 3 | 2012 | 11 | 1.080 |
Why?
| Free Tissue Flaps | 5 | 2023 | 56 | 0.960 |
Why?
| Vascular Endothelial Growth Factor A | 3 | 2009 | 230 | 0.880 |
Why?
| Recurrent Laryngeal Nerve Injuries | 1 | 2021 | 11 | 0.820 |
Why?
| Robotics | 1 | 2021 | 45 | 0.770 |
Why?
| Facial Paralysis | 2 | 2019 | 24 | 0.760 |
Why?
| Bone Plates | 2 | 2013 | 17 | 0.750 |
Why?
| Skin | 6 | 2010 | 469 | 0.730 |
Why?
| Nasolabial Fold | 1 | 2019 | 1 | 0.710 |
Why?
| Fracture Fixation | 2 | 2012 | 21 | 0.680 |
Why?
| Retrospective Studies | 25 | 2024 | 6432 | 0.680 |
Why?
| Neck | 5 | 2021 | 116 | 0.610 |
Why?
| Skin, Artificial | 2 | 2007 | 9 | 0.590 |
Why?
| Carcinoma, Squamous Cell | 6 | 2022 | 384 | 0.580 |
Why?
| Wound Healing | 4 | 2010 | 228 | 0.540 |
Why?
| Collagen | 2 | 2007 | 223 | 0.530 |
Why?
| Recurrent Laryngeal Nerve | 2 | 2021 | 20 | 0.520 |
Why?
| Laryngeal Nerves | 2 | 2021 | 19 | 0.520 |
Why?
| Neck Dissection | 4 | 2021 | 43 | 0.520 |
Why?
| Humans | 47 | 2024 | 54284 | 0.490 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2010 | 60 | 0.460 |
Why?
| Laryngectomy | 3 | 2010 | 28 | 0.460 |
Why?
| Tracheotomy | 1 | 2012 | 14 | 0.440 |
Why?
| Hypopharyngeal Neoplasms | 1 | 2012 | 8 | 0.440 |
Why?
| Oropharyngeal Neoplasms | 1 | 2012 | 14 | 0.440 |
Why?
| Forehead | 1 | 2012 | 10 | 0.430 |
Why?
| Gastrostomy | 1 | 2012 | 60 | 0.420 |
Why?
| Chemoradiotherapy | 1 | 2012 | 42 | 0.420 |
Why?
| Device Removal | 1 | 2013 | 97 | 0.420 |
Why?
| Nose | 1 | 2012 | 42 | 0.420 |
Why?
| Male | 27 | 2024 | 27334 | 0.400 |
Why?
| Rhytidoplasty | 1 | 2011 | 6 | 0.400 |
Why?
| Laser Therapy | 2 | 2011 | 91 | 0.390 |
Why?
| Face | 1 | 2011 | 66 | 0.380 |
Why?
| Middle Aged | 20 | 2024 | 13088 | 0.370 |
Why?
| Thyroidectomy | 2 | 2021 | 103 | 0.370 |
Why?
| Lasers | 2 | 2007 | 141 | 0.370 |
Why?
| Pharyngeal Diseases | 1 | 2010 | 12 | 0.370 |
Why?
| Laryngeal Neoplasms | 2 | 2007 | 55 | 0.360 |
Why?
| Follow-Up Studies | 7 | 2023 | 2387 | 0.360 |
Why?
| Cutaneous Fistula | 1 | 2010 | 16 | 0.360 |
Why?
| Rhinophyma | 1 | 2009 | 1 | 0.360 |
Why?
| Hemostasis, Surgical | 1 | 2009 | 12 | 0.360 |
Why?
| Fistula | 1 | 2010 | 28 | 0.360 |
Why?
| Molar | 1 | 2009 | 2 | 0.350 |
Why?
| Surgical Instruments | 1 | 2009 | 34 | 0.350 |
Why?
| Treatment Outcome | 10 | 2021 | 5604 | 0.350 |
Why?
| Biocompatible Materials | 2 | 2007 | 65 | 0.340 |
Why?
| Female | 25 | 2024 | 28441 | 0.340 |
Why?
| Receptors, Vascular Endothelial Growth Factor | 1 | 2008 | 25 | 0.340 |
Why?
| Port-Wine Stain | 1 | 2008 | 14 | 0.330 |
Why?
| Postoperative Complications | 6 | 2022 | 1033 | 0.320 |
Why?
| Arthrodermataceae | 1 | 2007 | 3 | 0.320 |
Why?
| Trichophyton | 1 | 2007 | 6 | 0.320 |
Why?
| Tinea | 1 | 2007 | 3 | 0.320 |
Why?
| Quality of Life | 2 | 2012 | 922 | 0.310 |
Why?
| Colony Count, Microbial | 1 | 2007 | 66 | 0.310 |
Why?
| Resins, Synthetic | 1 | 2007 | 3 | 0.310 |
Why?
| External Fixators | 1 | 2007 | 8 | 0.310 |
Why?
| Adult | 15 | 2024 | 14207 | 0.300 |
Why?
| Computer-Aided Design | 1 | 2007 | 21 | 0.300 |
Why?
| Nose Deformities, Acquired | 1 | 2007 | 2 | 0.300 |
Why?
| Nasal Septum | 1 | 2007 | 10 | 0.300 |
Why?
| Mandible | 1 | 2007 | 24 | 0.300 |
Why?
| Lasers, Solid-State | 1 | 2007 | 32 | 0.300 |
Why?
| Models, Anatomic | 1 | 2007 | 46 | 0.300 |
Why?
| Patient Care Planning | 1 | 2007 | 79 | 0.290 |
Why?
| Chi-Square Distribution | 4 | 2012 | 318 | 0.280 |
Why?
| Aged, 80 and over | 7 | 2022 | 3431 | 0.280 |
Why?
| Dermis | 1 | 2006 | 20 | 0.280 |
Why?
| Carcinoma | 3 | 2024 | 153 | 0.260 |
Why?
| Carcinoma, Merkel Cell | 2 | 2016 | 47 | 0.260 |
Why?
| Aged | 12 | 2024 | 10054 | 0.260 |
Why?
| Mandibular Condyle | 1 | 2004 | 6 | 0.260 |
Why?
| Reoperation | 2 | 2021 | 454 | 0.250 |
Why?
| Salivary Gland Neoplasms | 1 | 2024 | 24 | 0.240 |
Why?
| Head | 3 | 2021 | 77 | 0.240 |
Why?
| Mandibular Reconstruction | 1 | 2023 | 10 | 0.230 |
Why?
| Scapula | 1 | 2023 | 19 | 0.230 |
Why?
| Tramadol | 1 | 2022 | 29 | 0.220 |
Why?
| Intraoperative Care | 1 | 2021 | 57 | 0.200 |
Why?
| Glossectomy | 1 | 2021 | 6 | 0.200 |
Why?
| Tongue | 1 | 2021 | 41 | 0.200 |
Why?
| Chylothorax | 1 | 2021 | 16 | 0.200 |
Why?
| Hypotension | 1 | 2021 | 67 | 0.190 |
Why?
| Nuclear Proteins | 2 | 2015 | 252 | 0.190 |
Why?
| Vasoconstrictor Agents | 1 | 2021 | 88 | 0.190 |
Why?
| Arteries | 1 | 2021 | 101 | 0.190 |
Why?
| Morbidity | 1 | 2021 | 149 | 0.190 |
Why?
| Venous Thrombosis | 1 | 2021 | 102 | 0.190 |
Why?
| Intraoperative Complications | 1 | 2021 | 125 | 0.190 |
Why?
| Skin Neoplasms | 2 | 2016 | 532 | 0.180 |
Why?
| Analgesics, Opioid | 2 | 2022 | 501 | 0.180 |
Why?
| Acetaminophen | 1 | 2022 | 349 | 0.170 |
Why?
| Rats, Sprague-Dawley | 3 | 2009 | 1663 | 0.170 |
Why?
| Random Allocation | 2 | 2010 | 312 | 0.170 |
Why?
| Health Status Indicators | 1 | 2019 | 94 | 0.170 |
Why?
| Recovery of Function | 2 | 2012 | 222 | 0.160 |
Why?
| Neovascularization, Physiologic | 2 | 2009 | 72 | 0.160 |
Why?
| Patient Satisfaction | 1 | 2019 | 304 | 0.150 |
Why?
| Heart Defects, Congenital | 1 | 2023 | 608 | 0.150 |
Why?
| Time Factors | 4 | 2012 | 3213 | 0.150 |
Why?
| Rats | 3 | 2009 | 3415 | 0.140 |
Why?
| Benzoxazoles | 1 | 2016 | 12 | 0.140 |
Why?
| Tomography, X-Ray Computed | 3 | 2023 | 1213 | 0.140 |
Why?
| Risk Assessment | 2 | 2012 | 1361 | 0.140 |
Why?
| Animals | 7 | 2016 | 14385 | 0.140 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2016 | 85 | 0.130 |
Why?
| Proto-Oncogene Proteins c-myb | 1 | 2015 | 9 | 0.130 |
Why?
| Comorbidity | 2 | 2019 | 663 | 0.130 |
Why?
| Cell Proliferation | 2 | 2016 | 1096 | 0.130 |
Why?
| Pyrimidines | 1 | 2016 | 196 | 0.120 |
Why?
| Cohort Studies | 2 | 2024 | 1543 | 0.120 |
Why?
| Adolescent | 4 | 2009 | 6897 | 0.120 |
Why?
| Neoplasm Recurrence, Local | 3 | 2022 | 644 | 0.110 |
Why?
| Survival Analysis | 2 | 2012 | 735 | 0.110 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 866 | 0.110 |
Why?
| Jaw Fixation Techniques | 1 | 2012 | 2 | 0.110 |
Why?
| Cancer Care Facilities | 1 | 2012 | 21 | 0.110 |
Why?
| Apoptosis | 2 | 2016 | 1300 | 0.110 |
Why?
| Multiple Trauma | 1 | 2012 | 34 | 0.110 |
Why?
| Cartilage | 1 | 2012 | 47 | 0.100 |
Why?
| Leukoplakia, Oral | 1 | 2011 | 8 | 0.100 |
Why?
| Aminolevulinic Acid | 1 | 2011 | 10 | 0.100 |
Why?
| Lasers, Dye | 1 | 2011 | 10 | 0.100 |
Why?
| Enteral Nutrition | 1 | 2012 | 136 | 0.100 |
Why?
| Photosensitizing Agents | 1 | 2011 | 24 | 0.100 |
Why?
| Epigenesis, Genetic | 1 | 2015 | 399 | 0.100 |
Why?
| Photochemotherapy | 1 | 2011 | 37 | 0.100 |
Why?
| Thyroid Gland | 2 | 2022 | 93 | 0.100 |
Why?
| Transcription Factors | 1 | 2015 | 622 | 0.100 |
Why?
| Drug Resistance, Multiple | 1 | 2010 | 20 | 0.100 |
Why?
| Taxoids | 1 | 2010 | 45 | 0.100 |
Why?
| Pain, Postoperative | 2 | 2022 | 161 | 0.100 |
Why?
| Rotation | 1 | 2011 | 76 | 0.100 |
Why?
| Epigenomics | 1 | 2011 | 67 | 0.100 |
Why?
| Arkansas | 2 | 2019 | 2100 | 0.100 |
Why?
| Granulation Tissue | 1 | 2010 | 12 | 0.100 |
Why?
| Prospective Studies | 3 | 2022 | 2604 | 0.090 |
Why?
| Mice, Knockout | 2 | 2010 | 926 | 0.090 |
Why?
| Myeloid Cells | 1 | 2010 | 37 | 0.090 |
Why?
| Tissue and Organ Harvesting | 1 | 2010 | 27 | 0.090 |
Why?
| DNA, Neoplasm | 1 | 2011 | 171 | 0.090 |
Why?
| Pectoralis Muscles | 1 | 2010 | 9 | 0.090 |
Why?
| Biopsy, Fine-Needle | 1 | 2010 | 116 | 0.090 |
Why?
| Probability | 1 | 2010 | 176 | 0.090 |
Why?
| Neoplastic Stem Cells | 1 | 2011 | 103 | 0.090 |
Why?
| Microsatellite Instability | 1 | 2009 | 20 | 0.090 |
Why?
| Neoplasm Invasiveness | 2 | 2007 | 295 | 0.090 |
Why?
| Statistics, Nonparametric | 2 | 2007 | 232 | 0.090 |
Why?
| Esthetics | 1 | 2009 | 16 | 0.090 |
Why?
| Ultrasonography, Interventional | 1 | 2010 | 146 | 0.090 |
Why?
| Tooth Extraction | 1 | 2009 | 10 | 0.090 |
Why?
| Graft Rejection | 1 | 2010 | 161 | 0.090 |
Why?
| Gene Silencing | 1 | 2009 | 129 | 0.090 |
Why?
| Blood Loss, Surgical | 1 | 2009 | 79 | 0.080 |
Why?
| Mice | 4 | 2016 | 6413 | 0.080 |
Why?
| Immunohistochemistry | 2 | 2009 | 1089 | 0.080 |
Why?
| Paraffin Embedding | 1 | 2008 | 56 | 0.080 |
Why?
| Drug Resistance, Neoplasm | 1 | 2010 | 309 | 0.080 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 208 | 0.080 |
Why?
| Bone Wires | 1 | 2008 | 3 | 0.080 |
Why?
| Arteriovenous Malformations | 1 | 2009 | 66 | 0.080 |
Why?
| Quinones | 1 | 2007 | 11 | 0.080 |
Why?
| Mice, Inbred C57BL | 2 | 2010 | 1999 | 0.080 |
Why?
| Photomicrography | 1 | 2007 | 7 | 0.080 |
Why?
| Dental Occlusion | 1 | 2007 | 2 | 0.080 |
Why?
| Mandibular Neoplasms | 1 | 2007 | 8 | 0.080 |
Why?
| Carcinoma, Adenoid Cystic | 1 | 2007 | 10 | 0.080 |
Why?
| Jaw Diseases | 1 | 2007 | 7 | 0.080 |
Why?
| Ear Cartilage | 1 | 2007 | 5 | 0.080 |
Why?
| Skull Base Neoplasms | 1 | 2007 | 23 | 0.080 |
Why?
| Osteotomy | 1 | 2007 | 35 | 0.080 |
Why?
| Bone Transplantation | 1 | 2007 | 55 | 0.070 |
Why?
| Predictive Value of Tests | 1 | 2010 | 1048 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 673 | 0.070 |
Why?
| Osteonecrosis | 1 | 2007 | 36 | 0.070 |
Why?
| Salvage Therapy | 2 | 2022 | 145 | 0.070 |
Why?
| Sesquiterpenes | 1 | 2007 | 91 | 0.070 |
Why?
| Macrophages | 1 | 2009 | 405 | 0.070 |
Why?
| MicroRNAs | 1 | 2010 | 386 | 0.070 |
Why?
| Blood Vessels | 1 | 2007 | 78 | 0.070 |
Why?
| Equipment Design | 1 | 2007 | 318 | 0.070 |
Why?
| Transplantation, Heterologous | 1 | 2006 | 77 | 0.070 |
Why?
| Bone Density Conservation Agents | 1 | 2007 | 83 | 0.070 |
Why?
| Diphosphonates | 1 | 2007 | 96 | 0.070 |
Why?
| Swine | 1 | 2007 | 431 | 0.070 |
Why?
| Logistic Models | 1 | 2009 | 995 | 0.070 |
Why?
| Azepines | 2 | 2016 | 22 | 0.070 |
Why?
| Analysis of Variance | 1 | 2007 | 635 | 0.070 |
Why?
| Microsurgery | 2 | 2021 | 35 | 0.070 |
Why?
| Models, Theoretical | 1 | 2007 | 184 | 0.070 |
Why?
| Image Processing, Computer-Assisted | 1 | 2007 | 256 | 0.070 |
Why?
| Hypoglossal Nerve | 1 | 2005 | 4 | 0.070 |
Why?
| Stress, Mechanical | 1 | 2006 | 96 | 0.070 |
Why?
| Severity of Illness Index | 1 | 2009 | 1084 | 0.070 |
Why?
| Pilot Projects | 2 | 2022 | 808 | 0.070 |
Why?
| Carotid Arteries | 1 | 2005 | 82 | 0.060 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2016 | 219 | 0.060 |
Why?
| Neoplasm Staging | 1 | 2007 | 806 | 0.060 |
Why?
| Triazoles | 2 | 2016 | 120 | 0.060 |
Why?
| Fracture Healing | 1 | 2004 | 26 | 0.060 |
Why?
| Disease Models, Animal | 1 | 2010 | 1639 | 0.060 |
Why?
| Endoscopy | 1 | 2004 | 131 | 0.060 |
Why?
| Range of Motion, Articular | 1 | 2004 | 165 | 0.060 |
Why?
| Forearm | 1 | 2023 | 41 | 0.060 |
Why?
| Vascular Surgical Procedures | 1 | 2005 | 178 | 0.060 |
Why?
| Risk Factors | 1 | 2012 | 3935 | 0.060 |
Why?
| Ibuprofen | 1 | 2022 | 28 | 0.060 |
Why?
| Ambulatory Care Facilities | 1 | 2023 | 136 | 0.060 |
Why?
| Tumor Cells, Cultured | 2 | 2016 | 477 | 0.060 |
Why?
| Ambulatory Care | 1 | 2023 | 230 | 0.050 |
Why?
| Anastomosis, Surgical | 1 | 2021 | 72 | 0.050 |
Why?
| Infusions, Intravenous | 1 | 2021 | 231 | 0.050 |
Why?
| Neoplasms, Squamous Cell | 2 | 2011 | 9 | 0.050 |
Why?
| Drug Administration Schedule | 1 | 2021 | 401 | 0.050 |
Why?
| Promoter Regions, Genetic | 2 | 2015 | 520 | 0.050 |
Why?
| Odds Ratio | 1 | 2021 | 604 | 0.050 |
Why?
| Magnetic Resonance Imaging | 1 | 2007 | 1604 | 0.040 |
Why?
| Pain Management | 1 | 2021 | 155 | 0.040 |
Why?
| Child, Preschool | 1 | 2008 | 4147 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2023 | 1304 | 0.040 |
Why?
| Child | 2 | 2009 | 7341 | 0.040 |
Why?
| Critical Pathways | 1 | 2019 | 36 | 0.040 |
Why?
| Cell Line, Tumor | 2 | 2015 | 1550 | 0.040 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 1056 | 0.040 |
Why?
| Patient Readmission | 1 | 2019 | 242 | 0.040 |
Why?
| Sensitivity and Specificity | 2 | 2010 | 923 | 0.040 |
Why?
| Patient Discharge | 1 | 2019 | 353 | 0.040 |
Why?
| Mice, Inbred NOD | 1 | 2016 | 99 | 0.030 |
Why?
| Immunoenzyme Techniques | 1 | 2016 | 165 | 0.030 |
Why?
| Mice, SCID | 1 | 2016 | 196 | 0.030 |
Why?
| Drug Synergism | 1 | 2016 | 171 | 0.030 |
Why?
| Length of Stay | 1 | 2019 | 683 | 0.030 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 18 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 206 | 0.030 |
Why?
| Acetylation | 1 | 2015 | 99 | 0.030 |
Why?
| Enhancer Elements, Genetic | 1 | 2015 | 64 | 0.030 |
Why?
| Infant | 1 | 2024 | 3817 | 0.030 |
Why?
| Drug Therapy, Combination | 1 | 2016 | 426 | 0.030 |
Why?
| Neoplasm Metastasis | 1 | 2015 | 252 | 0.030 |
Why?
| Blotting, Western | 1 | 2016 | 683 | 0.030 |
Why?
| Chromatin | 1 | 2015 | 156 | 0.030 |
Why?
| Cell Cycle Proteins | 1 | 2015 | 199 | 0.030 |
Why?
| Protein Binding | 1 | 2015 | 736 | 0.030 |
Why?
| RNA, Messenger | 1 | 2016 | 1202 | 0.030 |
Why?
| Administration, Topical | 1 | 2011 | 71 | 0.030 |
Why?
| Pharmacogenetics | 1 | 2010 | 55 | 0.020 |
Why?
| Deferoxamine | 1 | 2009 | 12 | 0.020 |
Why?
| Treatment Failure | 1 | 2010 | 139 | 0.020 |
Why?
| Drug Combinations | 1 | 2009 | 128 | 0.020 |
Why?
| Keratinocytes | 1 | 2009 | 96 | 0.020 |
Why?
| Biopsy | 1 | 2011 | 692 | 0.020 |
Why?
| Lymphatic Metastasis | 1 | 2010 | 256 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2009 | 92 | 0.020 |
Why?
| Lipopolysaccharides | 1 | 2009 | 199 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2009 | 531 | 0.020 |
Why?
| Flow Cytometry | 1 | 2011 | 546 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2011 | 1476 | 0.020 |
Why?
| Cranial Nerve Neoplasms | 1 | 2007 | 6 | 0.020 |
Why?
| False Negative Reactions | 1 | 2007 | 36 | 0.020 |
Why?
| Radiographic Image Enhancement | 1 | 2007 | 32 | 0.020 |
Why?
| False Positive Reactions | 1 | 2007 | 68 | 0.020 |
Why?
| Dental Care | 1 | 2007 | 11 | 0.020 |
Why?
| Curettage | 1 | 2007 | 15 | 0.020 |
Why?
| Nitric Oxide | 1 | 2009 | 298 | 0.020 |
Why?
| Skin Temperature | 1 | 2007 | 19 | 0.020 |
Why?
| Image Enhancement | 1 | 2007 | 56 | 0.020 |
Why?
| Hyperbaric Oxygenation | 1 | 2007 | 17 | 0.020 |
Why?
| Survival Rate | 1 | 2009 | 951 | 0.020 |
Why?
| Adrenal Cortex Hormones | 1 | 2007 | 95 | 0.020 |
Why?
| Imidazoles | 1 | 2007 | 142 | 0.020 |
Why?
| Hot Temperature | 1 | 2007 | 199 | 0.020 |
Why?
| Contrast Media | 1 | 2007 | 221 | 0.020 |
Why?
| Cells, Cultured | 1 | 2009 | 1737 | 0.020 |
Why?
| DNA Methylation | 1 | 2009 | 574 | 0.020 |
Why?
| Cadaver | 1 | 2005 | 113 | 0.020 |
Why?
| Fluorouracil | 1 | 2004 | 61 | 0.020 |
Why?
| Lymph Node Excision | 1 | 2004 | 140 | 0.010 |
Why?
| Combined Modality Therapy | 1 | 2004 | 692 | 0.010 |
Why?
| Cisplatin | 1 | 2004 | 352 | 0.010 |
Why?
| Antineoplastic Agents | 1 | 2010 | 1300 | 0.010 |
Why?
| Anti-Bacterial Agents | 1 | 2007 | 820 | 0.010 |
Why?
| Young Adult | 1 | 2009 | 4318 | 0.010 |
Why?
| Cross-Sectional Studies | 1 | 2004 | 1693 | 0.010 |
Why?
| Multiple Myeloma | 1 | 2007 | 3035 | 0.010 |
Why?
|
|
Vural's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|